Luhn, Kerstin
93  Ergebnisse:
Personensuche X
?
1

Identification of early gene expression profiles associated..:

Blengio, Fabiola ; Hocini, Hakim ; Richert, Laura...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.celrep.2023.113101.  , 2023
 
?
2

Safety and immunogenicity of the two-dose heterologous Ad26..:

Choi, Edward Man-Lik ; Lacarra, Boris ; Afolabi, Muhammed O...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S2214-109X(23)00410-2.  , 2023
 
?
4

Identification of early gene expression profiles associated..:

Blengio, Fabiola ; Hocini, Hakim ; Richert, Laura...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.celrep.2023.113101.  , 2023
 
?
7

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine ..:

Man-Lik Choi, Edward ; Abu-Baker Mustapher, Ggayi ; Omosa-Manyonyi, Gloria...
https://researchonline.lshtm.ac.uk/id/eprint/4671457/1/1-s2.0-S0264410X23012574-main.pdf.  , 2023
 
?
 
?
9

Safety and immunogenicity of the two-dose heterologous Ad26..:

Choi, Edward Man-Lik ; Lacarra, Boris ; Afolabi, Muhammed O...
https://researchonline.lshtm.ac.uk/id/eprint/4671367/1/Choi-etal-2023-Safety-and-immunogenicity-of-the-two-dose-heterologous-Ad26.ZEBOV-and-MVA-BN-Filo-Ebola-vaccine-regimen-in-infants.pdf.  , 2023
 
?
10

Protocol for a phase 3 trial to evaluate the effectiveness ..:

Watson-Jones, Deborah ; Kavunga-Membo, Hugo ; Grais, Rebecca F...
https://researchonline.lshtm.ac.uk/id/eprint/4664990/1/e055596.full.pdf.  , 2022
 
?
13

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:

Anywaine, Zacchaeus ; Barry, Houreratou ; Anzala, Omu...
https://researchonline.lshtm.ac.uk/id/eprint/4664537/1/Safety%20and%20immunogenicity%20of%202-dose%20heterologous%20Ad26.ZEBOV,%20MVA-BN-Filo%20Ebola%20vaccination%20in%20children%20and%20adolescents%20in%20Af.pdf.  , 2022
 
1-15